Gene: FLT3LG
Official Full Name: fms related receptor tyrosine kinase 3 ligandprovided by HGNC
Gene Summary: Dendritic cells (DCs) provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses. FLT3LG controls the development of DCs and is particularly important for plasmacytoid DCs and CD8 (see MIM 186910)-positive classical DCs and their CD103 (ITGAE; MIM 604682)-positive tissue counterparts (summary by Sathaliyawala et al., 2010 [PubMed 20933441]).[supplied by OMIM, Jan 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09061 | FLT3LG Knockout cell line (HeLa) | Human | FLT3LG | 1:3~1:6 | Negative | Online Inquiry |
KO09062 | FLT3LG Knockout cell line (HCT 116) | Human | FLT3LG | 1:2~1:4 | Negative | Online Inquiry |
KO09063 | FLT3LG Knockout cell line (HEK293) | Human | FLT3LG | 1:3~1:6 | Negative | Online Inquiry |
KO09064 | FLT3LG Knockout cell line (A549) | Human | FLT3LG | 1:3~1:4 | Negative | Online Inquiry |
FLT3LG Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology, designed specifically for the study of FLT3 ligand signaling pathways and their implications in various biological processes. These cell lines have been genetically engineered to exhibit a complete disruption of the FLT3LG gene, allowing researchers to analyze the functional consequences of this loss in a controlled environment. By utilizing CRISPR/Cas9 technology, these knockout cell lines provide a robust model for investigating cellular responses, lineage commitment, and immune cell differentiation related to FLT3 signaling.
The primary mechanism through which these knockout cell lines operate is the ablation of the FLT3LG gene, which encodes a critical ligand for the FLT3 receptor on hematopoietic progenitor cells and dendritic cells. This disruption enables a detailed exploration of the role of FLT3 signaling in hematopoiesis and its involvement in pathologies such as leukemia and other hematological malignancies. Researchers can utilize these cell lines in various applications, including drug screening, pathway analysis, and immune response studies, providing essential insights into treatment strategies and therapeutic targets.
One of the unique selling points of FLT3LG Gene Knockout Cell Lines is their specificity and reliability for targeted research. Unlike other methods, such as traditional knockout strategies that may result in off-target effects or incomplete gene disruption, these engineered cell lines ensure a precise knockout of the FLT3LG gene, thus enhancing the reproducibility and accuracy of experimental outcomes. Moreover, their rapid adaptability allows for easy integration into a wide array of experimental setups, making them ideal for high-throughput screening applications.
For researchers and clinicians focused on understanding the complexities of FLT3 signaling and its implications, these knockout cell lines are invaluable. They offer a high-fidelity platform to unlock new therapeutic interventions and foster advancements in personalized medicine. Our company is committed to delivering high-quality biological products backed by extensive research and development, ensuring that our clients are equipped with the most sophisticated tools to advance their scientific endeavors. With our expertise and ongoing support, researchers can confidently explore uncharted territories in the realm of cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.